Golden opportunity

By applying medicinal chemistry to an old drug with strong but narrow-spectrum antibacterial properties, Auspherix Ltd. has discovered a new class of gold salt derivatives called organogolds that could preferentially target desired tissues to fight drug-resistant infections.

The biotech expects to enter the clinic in 2019 with one or more candidates that target and concentrate in areas in and around the bladder to treat chronic urinary tract infections (cUTI)...